CDKN2A and cancer: In the setting of pulmonary squamous cell carcinoma, p16 methylation is not only an early-stage event and potential diagnostic biomarker but also serves to differentiate a primary pulmonary lesion from a metastasis from a p16INK4a -overexpressing cancer, such as cervical squamous cell carcinoma [66].